Key statistics
On Monday, Edwards Lifesciences Corp (E1WL34:SAO) closed at 112.20, -7.23% below its 52-week high of 120.94, set on Dec 29, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 112.20 |
|---|---|
| High | 112.20 |
| Low | 112.20 |
| Bid | -- |
| Offer | -- |
| Previous close | 110.77 |
| Average volume | 231.80 |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Mar 02 2026 19:50 GMT.
More ▼
Press releases
- Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
- Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
- Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
- Edwards Comments on JenaValve Acquisition
- FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
- Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
More ▼
